AbbVie and RemeGen Forge Deal for Innovative Bispecific Antibody Targeting Solid Tumors #United_States #AbbVie #North_Chicago #RemeGen #RC148
0
0
0
0
AbbVie and RemeGen Forge Deal for Innovative Bispecific Antibody Targeting Solid Tumors #United_States #AbbVie #North_Chicago #RemeGen #RC148
FDA Approves RemeGen's Bispecific Antibody RC148 for Phase II Trials in the US #China #FDA_Approval #Yantai #RemeGen #RC148